Skip to main content

Parliamentary debates and questions

S5W-04712: Anas Sarwar (Glasgow)

Scottish Labour

Date lodged: 15 November 2016

To ask the Scottish Government for what reason the national treatment target for the hepatitis C virus (HCV) remained the same for 2016-17 when the cost of HCV medicines has reportdly reduced due to savings made in the tendering process.

Answered by: Aileen Campbell 23 November 2016

The treatment target is based on advice from the Treatment and Therapies sub-group. This group includes representatives from Health Protection Scotland, NHS Boards, National Procurement and patient representatives. Targets for 2016-17 were considered at a point when the treatment landscape was developing rapidly and during a period of high treatment demand. The group felt that in this context maintaining the target for a further year would provide the most stability to NHS Boards, but that the target should reviewed again for 2017-18. The national treatment target is a minimum target only and treatment numbers in 2016-17 are currently forecast to be 1871. This compares with 1724 treatments in 2015-16.